Left ventricular assist device as destination therapy in doxorubicin-induced cardiomyopathy.
Publication
, Journal Article
Simsir, SA; Lin, SS; Blue, LJ; Gockerman, JP; Russell, SD; Milano, CA
Published in: Ann Thorac Surg
August 2005
Doxorubicin-induced cardiomyopathy is not uncommon and may progress to end-stage heart failure. Treatment of this condition with heart transplantation, however, requires that the primary malignancy be deemed "cured." We present the case of a 55- year-old woman who had doxorubicin-induced cardiomyopathy and non-Hodgkin's lymphoma. The active status of her lymphoma precluded heart transplantation. She had end-stage heart failure and underwent the insertion of a left ventricular assist device as a destination therapy.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Ann Thorac Surg
DOI
EISSN
1552-6259
Publication Date
August 2005
Volume
80
Issue
2
Start / End Page
717 / 719
Location
Netherlands
Related Subject Headings
- Respiratory System
- Middle Aged
- Lymphoma, Non-Hodgkin
- Humans
- Heart-Assist Devices
- Heart Failure
- Female
- Doxorubicin
- Cardiomyopathies
- Antibiotics, Antineoplastic
Citation
APA
Chicago
ICMJE
MLA
NLM
Simsir, S. A., Lin, S. S., Blue, L. J., Gockerman, J. P., Russell, S. D., & Milano, C. A. (2005). Left ventricular assist device as destination therapy in doxorubicin-induced cardiomyopathy. Ann Thorac Surg, 80(2), 717–719. https://doi.org/10.1016/j.athoracsur.2004.02.036
Simsir, Sinan A., Shu S. Lin, Laura J. Blue, John P. Gockerman, Stuart D. Russell, and Carmelo A. Milano. “Left ventricular assist device as destination therapy in doxorubicin-induced cardiomyopathy.” Ann Thorac Surg 80, no. 2 (August 2005): 717–19. https://doi.org/10.1016/j.athoracsur.2004.02.036.
Simsir SA, Lin SS, Blue LJ, Gockerman JP, Russell SD, Milano CA. Left ventricular assist device as destination therapy in doxorubicin-induced cardiomyopathy. Ann Thorac Surg. 2005 Aug;80(2):717–9.
Simsir, Sinan A., et al. “Left ventricular assist device as destination therapy in doxorubicin-induced cardiomyopathy.” Ann Thorac Surg, vol. 80, no. 2, Aug. 2005, pp. 717–19. Pubmed, doi:10.1016/j.athoracsur.2004.02.036.
Simsir SA, Lin SS, Blue LJ, Gockerman JP, Russell SD, Milano CA. Left ventricular assist device as destination therapy in doxorubicin-induced cardiomyopathy. Ann Thorac Surg. 2005 Aug;80(2):717–719.
Published In
Ann Thorac Surg
DOI
EISSN
1552-6259
Publication Date
August 2005
Volume
80
Issue
2
Start / End Page
717 / 719
Location
Netherlands
Related Subject Headings
- Respiratory System
- Middle Aged
- Lymphoma, Non-Hodgkin
- Humans
- Heart-Assist Devices
- Heart Failure
- Female
- Doxorubicin
- Cardiomyopathies
- Antibiotics, Antineoplastic